The health secretary has told Labour MPs he can not back a change in the law because of the state of palliative care.

Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after an independent watchdog agency said the treatment isn’t worth the cost to ...

Stay informed about the US Elections 2024 with the latest news, key candidates, polling data, and voter information. Explore detailed insights on Kamala Harris and Donald Trump running in the ...

It can be daunting for those who need help to navigate a complex system that often prioritizes the wrong outcomes and is ...

Alzheimer’s drug donanemab for use in the country's national health service (NHS). The National Institute for Health and Care ...

As Medicare’s open enrollment season kicks off this year, more than 1 million patients will have to shop for new health ...

Bon Secours heard "loud and clear" that "preventative health care is constantly rising to the top of the conversation," said ...

Severe asthma and stomach pain sent Waxhaw man to the hospital. Now, unable to pay the thousands he owes, he has to cope with ...

A 2023 Pew Research Center study found that nearly three in 10 Black workers believe their employers pay too little attention ...

While all state Medicaid programs cover GLP-1 agonists for type 2 diabetes, it’s much less common for them to cover the drugs ...

Scott Balotin was convicted in 2021, but prosecutors asked to have the case dismissed after more information surfaced before ...

To continue reading and help Philly news thrive, unlock this exclusive offer for unlimited digital access to Inquirer.com and ...